BCL2L1 and osteosarcoma: Another study conducted by Wang et al. (2010) showed the protein and mRNA overexpression of anti-apoptotic Bcl-XL in high metastatic osteosarcoma cell line (M8), in contrary to low metastatic osteosarcoma cell lines (Saos-2, MG63 and U2OS).